Apr 30, 2026 06:30AM
Apr 21, 2026 08:37AM
Apr 21, 2026 06:45AM
Apr 21, 2026 06:45AM
Apr 20, 2026 06:48AM
Apr 20, 2026 06:48AM
Apr 13, 2026 07:01AM FDA grants priority review to ifinatamab deruxtecan for lung cancer treatment
Apr 13, 2026 07:00AM
Mar 2, 2026 06:26AM
Feb 28, 2026 10:05AM
Feb 28, 2026 10:05AM
Feb 28, 2026 10:00AM
Feb 25, 2026 12:37PM
Feb 25, 2026 12:37PM Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1
Feb 3, 2026 06:30AM
Nov 19, 2025 06:45AM
Nov 19, 2025 06:45AM
Oct 23, 2025 06:00AM
Oct 23, 2025 06:00AM
Oct 18, 2025 10:35AM
Oct 15, 2025 06:45AM Merck presents new HIV drug trial data on weight and lipid effects
Oct 15, 2025 06:45AM
Sep 19, 2025 06:45AM
Sep 19, 2025 06:45AM
Jul 29, 2025 06:30AM
Jul 10, 2025 06:45AM
Jul 10, 2025 06:45AM
Jul 2, 2025 06:45AM Merck (MRK) Granted FDA Priority Review for WINREVAIR to Update Label Based on Results From ZENITH Trial
Jul 2, 2025 06:45AM
Jun 13, 2025 11:43AM
Apr 27, 2025 12:00PM
Apr 24, 2025 06:30AM
Mar 27, 2025 11:01AM
Mar 27, 2025 11:01AM
Feb 25, 2025 06:45AM Merck (MRK) Granted FDA Priority Review to Application for KEYTRUDA Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Feb 25, 2025 06:45AM
Feb 4, 2025 06:30AM
Jan 27, 2025 06:45AM
Dec 17, 2024 06:46AM
Dec 17, 2024 06:45AM
Dec 11, 2024 09:44AM
Jul 30, 2024 06:30AM Merck Announces Second-Quarter 2024 Financial Results
May 29, 2024 07:17AM
May 29, 2024 07:15AM
May 9, 2024 06:46AM
May 9, 2024 06:45AM
May 7, 2024 04:00PM
Apr 29, 2024 09:01AM
Apr 29, 2024 09:00AM Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
Apr 25, 2024 06:30AM

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All